Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.
P/E ratio for Titan Medical Inc. (TMDI)
P/E ratio as of 2021: -2.82
According to Titan Medical Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.82. At the end of 2020 the company had a P/E ratio of -4.53.
P/E ratio history for Titan Medical Inc. from 2007 to 2021
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2021 | -2.82 |
| 2020 | -4.53 |
| 2019 | -0.36 |
| 2018 | -0.90 |
| 2017 | -1.39 |
| 2016 | -1.24 |
| 2015 | -0.50 |
| 2014 | -1.38 |
| 2013 | -1.52 |
| 2012 | -1.62 |
| 2011 | -0.68 |
| 2010 | -2.29 |
| 2009 | -9.21 |
| 2008 | -2.00 |
| 2007 | -0.69 |